Finance

Lists
Why is 4534 down 2,83%?
Dive Deeper
4534:TYO
Mochida Pharmaceutical Co Ltd
3 090,00 JPY
-2,83%
(-90,00) 1D
2 ოქტ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4534...
Open
3 150 JPY
High
3 150 JPY
Low
3 080 JPY
Mkt. cap
112,45 მლრ.
Avg. vol.
42,70 ათ.
Volume
66,80 ათ.
Dividend
2,59%
Quarterly dividend
20 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
11,92
52-wk high
3 965 JPY
52-wk low
2 929 JPY
EPS
259 JPY
Shares outstanding
19,85 მლნ.
No. of employees
1 ათ.
Open
3 150 JPY
High
3 150 JPY
Low
3 080 JPY
Mkt. cap
112,45 მლრ.
Avg. vol.
42,70 ათ.
Volume
66,80 ათ.
Dividend
2,59%
Quarterly dividend
20 JPY
Ex-dividend date
29 სექ. 2026
P/E ratio
11,92
52-wk high
3 965 JPY
52-wk low
2 929 JPY
EPS
259 JPY
Shares outstanding
19,85 მლნ.
No. of employees
1 ათ.
News stories
From web sources and news partners
Profile
Mochida Pharmaceutical Co., Ltd is a Japanese pharmaceutical company. One of its products is the antidepressant setiptiline. Wikipedia
About Mochida Pharmaceutical Co Ltd
CEO-
Employees1,48 ათ.
Founded28 აპრ. 1945
Headquartersშინჯუკუ, ტოკიო, იაპონია
SectorPharmaceutical industry
Websitemochida.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
28,35 მლრდ.
32,50 მლრდ.
29,46 მლრდ.
31,72 მლრდ.
Cost of goods sold
15,13 მლრდ.
17,50 მლრდ.
15,06 მლრდ.
17,03 მლრდ.
Cost of revenue
15,13 მლრდ.
17,50 მლრდ.
15,06 მლრდ.
17,03 მლრდ.
Research and development expenses
-
-
12,16 მლრდ.
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10,83 მლრდ.
12,45 მლრდ.
-376,00 მლნ.
11,12 მლრდ.
Operating expense
10,83 მლრდ.
12,45 მლრდ.
11,78 მლრდ.
11,12 მლრდ.
Total operating expenses
25,96 მლრდ.
29,94 მლრდ.
26,84 მლრდ.
28,15 მლრდ.
Operating income
2,40 მლრდ.
2,56 მლრდ.
2,62 მლრდ.
3,56 მლრდ.
Other non operating income
31,00 მლნ.
-67,00 მლნ.
12,00 მლნ.
34,00 მლნ.
EBT including unusual items
2,40 მლრდ.
3,17 მლრდ.
2,82 მლრდ.
4,86 მლრდ.
EBT excluding unusual items
2,40 მლრდ.
3,17 მლრდ.
2,85 მლრდ.
4,19 მლრდ.
Income tax expense
435,00 მლნ.
681,00 მლნ.
1,26 მლრდ.
1,69 მლრდ.
Effective tax rate
18,15%
21,50%
44,72%
34,68%
Other operating expenses
-
-
-
-
Net income
1,96 მლრდ.
2,49 მლრდ.
1,56 მლრდ.
3,18 მლრდ.
Net profit margin
6,92%
7,65%
5,30%
10,02%
Earnings per share
-
-
-
-
Interest and investment income
42,00 მლნ.
232,00 მლნ.
42,00 მლნ.
297,00 მლნ.
Interest expense
-1,00 მლნ.
-29,00 მლნ.
-42,00 მლნ.
-43,00 მლნ.
Net interest expenses
41,00 მლნ.
203,00 მლნ.
-
254,00 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,11 მლრდ.
-
3,37 მლრდ.
4,31 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები